USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ANTIGENICS, INC.
Address:
ANTIGENICS, INC.
34 COMMERCE WAY
WOBURN, MA 01801
Phone:
(781) 721-3518
URL:
N/A
EIN:
61562417
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $416,708.00 3
STTR Phase I $302,541.00 1

Award List:

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$127,989.00
Agency:
HHS
Principal Investigator:
Gerald A. Beltz
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Cheryl I. Murphy
Abstract:
N/a

A P. falciparum MSP1 p42/QS-21 malaria vaccine

Award Year / Program / Phase:
2001 / STTR / Phase I
Award Amount:
$302,541.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF HAWAII
RI Contact:
N/A
Abstract:
DESCRIPTION: (Adapted from Applicant's Abstract) Malaria is a disease which affects more than 300 million people each year and is fatal for 1.5 million. The overall objective of this STTR Phase I project is to produce a cGMP malaria vaccine consisting of the 42 kDa C-terminal… More

Heat Shock Protein based vaccine for Tuberculosis

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$188,719.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Mycobacterium tuberculosis is a continuing health threat both in the United States and the rest of the world with an estimated two billion people currently infected worldwide. Antibiotic regimens requiring lengthy direct observation of patients and the emergence… More